PT Medikaloka Hermina Tbk

PT Medikaloka Hermina Tbk

IIDX:HEAL
500.00
IDR
-5.00
(-0.99%)
30.69EPS
34.07P/E
12.43TMarket Cap
Oct 30Next Earn
PT Medikaloka Hermina Tbk
IDX:HEAL
(Indonesia Stock Exchange)

Recent

price

500.00

P/E

ratio

34.07

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
IDR
118.75
155.25
186.1
217.91
244.26
297.82
399.12
338.89
398.88
452.58
471.66
466.29
Revenue per Share
1.34
4.31
6.78
8.86
17.18
31.91
67.73
20.64
30.16
36.11
28.4
23.92
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
1.9
2.51
3.64
- -
2.2
2.4
5
5.99
7
8.53
10.28
- -
Dividend per Share
60.88
80.21
30.56
125.52
144.45
176.1
225.77
237.62
265.76
298.99
369.43
361.72
Book Value per Share
60.88
80.21
30.56
125.52
144.45
176.1
225.77
237.62
265.76
298.99
369.43
361.72
Tangible Book Value per Share
14,391
14,391
14,391
14,034
14,865
14,828
14,705
14,464
14,501
14,842
15,124
15,336
Basic Weighted Avg Shares
1,709,020
2,234,263
2,678,197
3,058,091
3,630,940
4,416,042
5,869,014
4,901,810
5,784,084
6,717,179
7,133,538
7,151,069
Sales/Revenue/Turnover
13.4
13.94
14.42
11.45
15.21
21.97
29.57
10.53
13.5
15.43
13.2
11.82
Operating Margin (%)
60,749
89,662
105,603
72,230
51,596
67,540
93,819
192,624
250,796
259,340
279,343
286,263
Depreciation Expense
19,298
61,996
97,549
124,374
255,367
473,222
995,974
298,596
437,346
535,942
429,547
366,826
Net Income, GAAP
31.55
29.34
37.77
30.67
31.96
31.75
21.61
21.1
21.27
24.03
27.28
27.34
Effective Tax Rate (%)
1.13
2.77
3.64
4.07
7.03
10.72
16.97
6.09
7.56
7.98
6.02
5.13
Profit Margin (%)
-74,990
-81,239
-799,498
188,534
620,158
772,744
848,621
80,622
397,267
228,553
427,684
474,396
Working Capital
292,712
506,916
561,809
601,037
1,064,544
1,297,595
1,474,537
1,162,377
2,002,702
2,829,775
2,644,465
3,033,278
LT Debt
957,588
1,259,960
956,529
2,369,709
2,764,434
3,450,124
4,432,592
4,685,473
5,198,326
5,866,219
7,209,847
7,097,086
Total Equity
- -
14.91
11.01
9.35
10.71
15.15
23.74
7.16
9.11
9.55
7.13
6.21
Return on Invested Capital (%)
- -
5.43
3.2
5.28
6.6
8.57
14.64
5.25
6.13
6.26
4.95
4.37
Return on Capital (%)
- -
5.91
11.85
10.72
12.73
19.91
33.68
8.85
11.97
12.88
8.48
7.27
Return on Common Equity (%)

Capital Structure

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
580,901
587,880
604,844
LT Borrowings
2,638,881
2,903,459
3,022,704
LT Finance Leases
5,584
5,259
10,574
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
15,366
15,319
15,246
Market Capitalization
21,128,181
20,144,530
12,425,244

Working Capital

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,366,885
2,444,745
2,224,782
Cash, Cash Equivalents & STI
727,793
844,634
571,787
Accounts Receivable, Net
1,313,752
1,275,092
1,297,566
Inventories
168,953
151,518
130,692
Total Current Liabilities
1,939,201
1,791,953
1,750,386
Payables & Accruals
- -
- -
- -
ST Debt
580,901
587,880
604,844
Deferred Revenue
- -
- -
- -

Growth Rates

IDR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
27.76%
16.18%
22.9%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
58.64%
17.92%
-19.85%
Sales/Revenue/Turnover
16.19%
11.35%
6.2%
Total Cash Common Dividend
- -
37.85%
22.84%

Quarterly Revenue

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,706,410
1,637,846
1,682,272
1,710,202
6,717,179
2025
1,692,471
1,696,090
- -
1,845,570
7,133,538
2026
1,783,206
1,826,203
- -
- -
- -

Quarterly Earnings Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
12.96
10.23
8.38
4.55
36.11
2025
8.12
6.52
- -
4.79
28.4
2026
6.6
6.02
- -
- -
- -

Quarterly Dividends Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
8.53
2025
- -
- -
- -
- -
10.28
2026
- -
- -
- -
- -
- -
Business
PT Medikaloka Hermina Tbk manages an extensive network of general hospitals throughout Indonesia. The company currently operates 51 hospitals across 36 cities, providing a total capacity of 8,287 beds. Established in 1985, the group offers a comprehensive range of medical services with a particular emphasis on women's and children's healthcare, in addition to various specialized treatments. A significant portion of its operations is dedicated to serving patients under the National Social Care Security (JKN) program, supporting wider access to healthcare. Headquartered in Jakarta, Indonesia, the company continues to expand its reach with new facilities under development.